Cypherpunk Technologies, Inc. (CYPH)
1.67
-0.04
(-2.34%)
USD |
NASDAQ |
Sep 02, 09:33
Cypherpunk Technologies 1 Year Total Returns (Daily) : 492.9% for Sept. 1, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 01, 2026 | 492.9% |
| August 31, 2026 | 532.8% |
| August 28, 2026 | 479.3% |
| August 27, 2026 | 550.2% |
| August 26, 2026 | 450.1% |
| August 25, 2026 | 429.0% |
| August 24, 2026 | 464.1% |
| August 21, 2026 | 416.4% |
| August 20, 2026 | 343.4% |
| August 19, 2026 | 273.6% |
| August 18, 2026 | 179.3% |
| August 17, 2026 | 163.1% |
| August 14, 2026 | 164.4% |
| August 13, 2026 | 91.15% |
| August 12, 2026 | 103.4% |
| August 11, 2026 | 117.9% |
| August 10, 2026 | 115.4% |
| August 07, 2026 | 118.0% |
| August 06, 2026 | 106.6% |
| August 05, 2026 | 122.8% |
| August 04, 2026 | 92.36% |
| August 03, 2026 | 108.1% |
| July 31, 2026 | 90.52% |
| July 30, 2026 | 94.47% |
| July 29, 2026 | 79.91% |
| Date | Value |
|---|---|
| July 28, 2026 | 80.83% |
| July 27, 2026 | 74.26% |
| July 24, 2026 | 70.09% |
| July 23, 2026 | 85.05% |
| July 22, 2026 | 91.51% |
| July 21, 2026 | 118.0% |
| July 20, 2026 | 108.4% |
| July 17, 2026 | 107.7% |
| July 16, 2026 | 103.6% |
| July 15, 2026 | 124.8% |
| July 14, 2026 | 121.7% |
| July 13, 2026 | 111.8% |
| July 10, 2026 | 97.89% |
| July 09, 2026 | 105.5% |
| July 08, 2026 | 104.8% |
| July 07, 2026 | 146.7% |
| July 06, 2026 | 131.6% |
| July 02, 2026 | 131.2% |
| July 01, 2026 | 117.4% |
| June 30, 2026 | 106.2% |
| June 29, 2026 | 142.7% |
| June 26, 2026 | 121.1% |
| June 25, 2026 | 112.0% |
| June 24, 2026 | 117.8% |
| June 23, 2026 | 111.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Indaptus Therapeutics, Inc. | -82.62% |
| ACADIA Pharmaceuticals, Inc. | 11.16% |
| Alnylam Pharmaceuticals, Inc. | -44.88% |
| Anika Therapeutics, Inc. | 125.1% |
| Savara, Inc. | 63.11% |